Statement Of Cash Flows [Abstract]

Captor Therapeutics S.A. - Filing #6272138

Concept As at
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2019-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
57 435 477 PLN
7 107 936 PLN
Cash flows from (used in) operating activities
57 435 477 PLN
7 107 936 PLN
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
8 579 410 PLN
34 846 861 PLN
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
1 435 569 PLN
1 069 880 PLN
Proceeds from government grants, classified as financing activities
21 852 452 PLN
22 983 775 PLN
Interest paid, classified as financing activities
31 483 PLN
77 567 PLN
Cash flows from (used in) financing activities
20 448 366 PLN
24 131 222 PLN
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
86 463 253 PLN
17 823 575 PLN
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
0 PLN
0 PLN
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
86 463 253 PLN
17 823 575 PLN
Cash and cash equivalents
120 502 324 PLN
34 039 071 PLN
51 862 646 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.